Globe Life (NYSE:GL) Issues FY 2027 Earnings Guidance

Globe Life (NYSE:GL) updated its FY 2027 earnings guidance on Friday morning. The company provided EPS guidance of 16.100-17.100 for the period, compared to the consensus earnings per share estimate of 16.510. Globe Life also updated its FY 2026 guidance to 15.350-15.650 EPS.

Globe Life Trading Down 8.2%

Shares of NYSE:GL traded down $13.79 during trading on Friday, reaching $154.62. 1,651,226 shares of the company were exchanged, compared to its average volume of 505,383. The business’s fifty day simple moving average is $169.95 and its 200-day simple moving average is $167.16. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life has a 12-month low of $127.85 and a 12-month high of $191.55. The firm has a market capitalization of $11.88 billion, a PE ratio of 10.34 and a beta of 0.44.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, October 21st. The company reported $4.84 EPS for the quarter, missing the consensus estimate of $4.90 by ($0.06). The firm had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.56 billion. Globe Life had a net margin of 18.89% and a return on equity of 19.95%. The business’s quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $4.81 EPS. On average, research analysts anticipate that Globe Life will post 15.65 EPS for the current year.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Monday, October 5th. Globe Life’s payout ratio is 8.76%.

Globe Life declared that its Board of Directors has initiated a share repurchase program on Monday, August 10th that allows the company to buy back $2.50 billion in shares. This buyback authorization allows the company to reacquire up to 17.7% of its shares through open market purchases. Share buyback programs are often an indication that the company’s board believes its stock is undervalued.

Analyst Ratings Changes

A number of research firms recently commented on GL. JPMorgan Chase & Co. lifted their target price on shares of Globe Life from $193.00 to $195.00 and gave the stock an “overweight” rating in a research note on Thursday, October 15th. Wells Fargo & Company raised their price target on shares of Globe Life from $190.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 12th. Weiss Ratings upgraded shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday. Morgan Stanley dropped their price objective on shares of Globe Life from $208.00 to $197.00 and set an “overweight” rating on the stock in a report on Monday, October 5th. Finally, Keefe, Bruyette & Woods cut their target price on Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a research report on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $182.60.

Insiders Place Their Bets

In related news, EVP Robert Hensley sold 10,000 shares of Globe Life stock in a transaction on Tuesday, September 22nd. The shares were sold at an average price of $170.07, for a total value of $1,700,700.00. Following the sale, the executive vice president owned 12,384 shares of the company’s stock, valued at approximately $2,106,146.88. This trade represents a 44.67% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Thomas Kalmbach sold 25,650 shares of Globe Life stock in a transaction dated Tuesday, July 28th. The shares were sold at an average price of $178.58, for a total transaction of $4,580,577.00. Following the completion of the sale, the chief financial officer owned 50,568 shares in the company, valued at approximately $9,030,433.44. This trade represents a 33.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 143,650 shares of company stock worth $25,793,717. Company insiders own 2.11% of the company’s stock.

Globe Life News Summary

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life projected 2027 adjusted earnings of $16.10–$17.10 per share, with the midpoint modestly above the current consensus estimate of $16.51. Management also targeted $850 million–$950 million in parent excess cash flow, supporting potential capital returns. Globe Life projects 2027 EPS and excess cash flow
• Positive Sentiment: TD Cowen maintained a Buy rating, although it reduced its price target from $225 to $215. The revised target still implies substantial potential upside based on the referenced share price. TD Cowen price target update
• Neutral Sentiment: Management’s 2027 EPS guidance range spans $16.10–$17.10, indicating continued growth potential but also a relatively wide range of outcomes. The company’s quarterly revenue and investment income benefited from growth in premiums and investments. Globe Life earnings guidance
• Negative Sentiment: Globe Life reported third-quarter EPS of $4.84, below analyst expectations near $4.87–$4.90. Weaker underwriting income, rising expenses and a reported $6.4 million underwriting loss offset higher premiums and investment income. Globe Life Q3 earnings miss
• Negative Sentiment: Globe Life lowered its 2026 EPS guidance to $15.35–$15.65, below the $15.72 consensus estimate. The weaker outlook was linked in part to losses at Evry Health, increasing concerns about profitability and execution. Evry Health losses and Globe Life guidance
• Negative Sentiment: Piper Sandler downgraded Globe Life, arguing that the stock is no longer a “predictable safe haven” following the earnings release. The downgrade adds pressure to investor sentiment after the earnings miss and guidance reduction. Piper Sandler downgrades Globe Life

Globe Life Company Profile

Globe Life Inc (NYSE: GL) is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.